Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. BB Biotech AG
  6. Summary
    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
87.4(c) 87.8(c) 87.85(c) 88.1(c) 88.6(c) Last
62 911 32 366 38 067 55 350 85 987 Volume
-0.29% +0.46% +0.06% +0.28% +0.57% Change
More quotes
Estimated financial data (e)
Sales 2021 130 M 139 M 139 M
Net income 2021 439 M 471 M 471 M
Net Debt 2021 23,5 M 25,1 M 25,1 M
P/E ratio 2021 8,71x
Yield 2021 4,54%
Sales 2022 0,25 M 0,27 M 0,27 M
Net income 2022 294 M 315 M 315 M
Net Debt 2022 23,2 M 24,9 M 24,9 M
P/E ratio 2022 17,4x
Yield 2022 4,82%
Capitalization 4 908 M 5 273 M 5 263 M
EV / Sales 2021 37,9x
EV / Sales 2022 19 727x
Nbr of Employees 10
Free-Float 98,2%
More Financials
Company
BB Biotech is a portfolio company that specializes in investments in biotechnology companies. At the end of 2018, the stock portfolio, assessed at market value to be EUR3,064.2 million, breaks down by type of holding as follows: - listed companies (99.9%): primarily Ionis Pharmaceuticals (rare diseases), Gilead Sciences (infectious viral diseases and flu), Celgene Corporation (cancer and inflammation of the immune... 
Sector
Biotechnology & Medical Research
Calendar
10/22 | 01:00amEarnings Release
More about the company
Ratings of BB Biotech AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about BB BIOTECH AG
07/29EQS-ADHOC : Bellevue's bottom-line profit quadruples to CHF 22.5 mn - assets und..
DJ
07/23Bb Biotech Ag Reports Earnings Results for the Second Quarter Ended June 30, ..
CI
07/23BB BIOTECH : Posts Lower H1 Profit, Operating Income
MT
07/23BB BIOTECH : Interim report as at June 30, 2021
PU
07/23BB BIOTECH : publishes its interim report
EQ
07/23BB BIOTECH : Solid second quarter for the biotech industry - BB Biotech raised i..
EQ
07/23DGAP-ADHOC : BB Biotech AG pubblica il proprio rapporto intermedio
DJ
07/23DGAP-NEWS : Il settore delle biotecnologie -2-
DJ
07/23DGAP-ADHOC : BB Biotech AG publishes its interim report
DJ
07/23DGAP-NEWS : Il settore delle biotecnologie archivia un secondo trimestre all'ins..
DJ
07/23PRESS RELEASE : Solid second quarter for the -2-
DJ
07/23PRESS RELEASE : Solid second quarter for the biotech industry - BB Biotech raise..
DJ
07/23BB Biotech Ag Announces Board Changes
CI
05/28BB BIOTECH : investment trust review highlights long t...
PU
05/27PRESS RELEASE : VAXIMM to Attend International Scientific and Industry Events
DJ
More news
News in other languages on BB BIOTECH AG
09/01BB BIOTECH : Zulassung von Alzheimermedikament erregt Aufsehen
08/30BB BIOTECH : Vier Gründe für BioTech-Aktien
08/06FINANZA : si conclude Mid & Small Virtual Summer, 27 societa' presentate
08/04L'agenda della settimana
07/29Bellevue profite de résultats semestriels en nette hausse
More news
Analyst Recommendations on BB BIOTECH AG
More recommendations
Chart BB BIOTECH AG
Duration : Period :
BB Biotech AG Technical Analysis Chart | BION | CH0038389992 | MarketScreener
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 88,60 CHF
Average target price 95,50 CHF
Spread / Average Target 7,79%
EPS Revisions
Managers and Directors
Michael Hutter Head-Finance & Compliance
Erich Hunziker Chairman-Supervisory Board
Daniel Koller Head-Investment Management
Clive A. Meanwell Vice Chairman-Supervisory Board
Thomas von Planta Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BB BIOTECH AG19.49%5 273
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420